MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. (Q40451918)

20 September 2017

title

MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. (English)

1 reference

20 September 2017

1 reference

2

Silke Soucek

1 reference

20 September 2017

4

Gerhard Ehninger

1 reference

20 September 2017

3

Christian Thiede

1 reference

20 September 2017

1

Markus Schaich

1 reference

20 September 2017

5

Thomas Illmer

1 reference

20 September 2017

author name string

SHG AML96 Study Group

series ordinal

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

British Journal of Haematology

20 September 2017

published in

1 reference

20 September 2017

volume

128

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

324-332

1 reference

Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Role of MRP1 in multidrug resistance in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

MDR1 gene expression and drug resistance of AML cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

LRP overexpression in monocytic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2004.05319.X

10.1111/J.1365-2141.2004.05319.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference